GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Curiox Biosystems Co Ltd (XKRX:445680) » Definitions » COGS-to-Revenue

Curiox Biosystems Co (XKRX:445680) COGS-to-Revenue : 0.33 (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Curiox Biosystems Co COGS-to-Revenue?

Curiox Biosystems Co's Cost of Goods Sold for the three months ended in Mar. 2025 was ₩305 Mil. Its Revenue for the three months ended in Mar. 2025 was ₩922 Mil.

Curiox Biosystems Co's COGS to Revenue for the three months ended in Mar. 2025 was 0.33.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Curiox Biosystems Co's Gross Margin % for the three months ended in Mar. 2025 was 66.91%.


Curiox Biosystems Co COGS-to-Revenue Historical Data

The historical data trend for Curiox Biosystems Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curiox Biosystems Co COGS-to-Revenue Chart

Curiox Biosystems Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
Get a 7-Day Free Trial 0.33 0.37 0.35 0.44 0.44

Curiox Biosystems Co Quarterly Data
Dec19 Dec20 Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.46 0.46 0.36 0.33

Curiox Biosystems Co COGS-to-Revenue Calculation

Curiox Biosystems Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=2028.866 / 4587.637
=0.44

Curiox Biosystems Co's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=305.031 / 921.853
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curiox Biosystems Co  (XKRX:445680) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Curiox Biosystems Co's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 305.031 / 921.853
=66.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Curiox Biosystems Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Curiox Biosystems Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Curiox Biosystems Co Business Description

Traded in Other Exchanges
N/A
Address
Samsung Harrington IT Tower, 204-213, 202, 2nd Floor, 9 Gil 41 Digital-Ro, Geumchun-Gu, Seoul, KOR, 08511
Curiox Biosystems Co Ltd is Korean Based company which brings together decades of scientific and engineering expertise in surface chemistry and life science instrumentation with the goal of overcoming critical challenges that slow the pace of life science research. The company has introduced Laminar Wash technology, which automates cell processing and enables highly reproducible and high-throughput cell analysis. The company offers various products such as LAMINAR WASH AUTO 1000 SYSTEM, Curiox Laminar Wash HT2000 System and Laminar Wash MINI System.

Curiox Biosystems Co Headlines

No Headlines